Plan aims to solve long-standing issue of access to medicines
Accelerated Access Review
New £86 million fund aims to speed up patient access to innovative digital technologies.
Proposals fall short of ambitions of Accelerated Access Review.
Big pharma could take its money elsewhere post Brexit, report warns.
NICE, regulator and NHS should work together, according to review.
What can the AAR do for the UK pharma industry, the health service and patients?